Articles On Genetic Technologies (ASX:GTG)

The ASX200 is riding Wall Street’s coattails today up 044% Nine out of eleven sectors were higher, with real estate leading the charge Technology was a close second with the help of a unicorn takeover bid   Wall Street rallied on Friday a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragusa Metals: up 60% Local markets took off at the open, feeling a little of the excitement which took hold of Wall Street overnight. The bench...

ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g...

Small cap index up 3% ASX 200 is up 1% Wall Street jumps as The Fed asks how high The ASX 200 is up 1% and the Emerging Companies (XEC) index is about 3% higher and the wee buy now pay later’s are the heroes of the dish. But first…   Over...

  Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mover...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Benchmark up circa 1%, small caps surge 1.5% Coal miners eclipsed by Whitehaven record profits Kincora Copper finds so much more copper The small cap S&P/ASX Emerging Companies (XEC) index and the benchmark S&P/ASX 200 (XJO) index...

Ansell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compounds  to >125 Genetic Technologies partners with Melbourne based Siles Health Protective personal equipment Ansell (ASX:ANN) has just annou...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

Cynata receives notice from the US Patent Office GTG completes acquisition of AffinityDNA Dental clinic network Pacific Smiles announces earnings guidance Cell therapeutics specialist, Cynata Therapeutics (ASX:CYP), has just received a No...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Genetic Technologies (ASX:GTG) has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.

The ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset big losses for energy, resources, materials. South Korea, Kiwi’s lift rates ahead of tonight’s US CPI read Investors are facing crunch time...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Genetic Technologies (GTG) embarks on a significant expansion of its recent acquisition of EasyDNA in both its test portfolio and geographical reach EasyDNA had expanded the availability of its carrier testing and non-invasive prenatal tes...

Small Caps, ASX 200 accelerate after RBA rate call Cash rate to 1.35%, Capital Economics says 3.5% the target EasyDNA rocks GTG world   Forget the RBA, it’s small cap day at Stockhead  as the Little Legends index ignores war, floods, flu,...

Prescient gets US patent approval Genetic Technologies expands EasyDNA into India and Europe Imricor submits cardiac ablation catheter for EU market Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has been granted a US p...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Literally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeover offer from US unicorn Deel Tempest Minerals signed JV to explore near the Karara Magnetite Iron mine June was a month of global econom...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper, shares up 70%   Aussie small caps have copped a commodities shellacking to start the week as materials, metals and energy stocks bear the...

Proteomics has completed a manufacturing technology transfer of its PromarkerD test Genetic Technologies build model that could create pathway in the US Proteomics proves it can produce the PromarkerD tests at scale Proteomics Internation...

Genetic Technologies (ASX:GTG) has completed an independently developed and validated customisable Budget Impact Model that it says demonstrates significant health and economic benefits directly attributed to the implementation of g...

Benchmark and small cap index down hard Life on the indices can be hard, unless your in energy, possibly materials Pearl Gull Iron is an island, literally and figuratively   The ASX200 and its emerging companies sidekick have retreated in...

Both ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken China hits resources stocks Appen in trading halt after jumping 30%     Local markets took a turn for the worse on Thursday after Chinese Prem...

Aussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher   Rising gold prices and teetering tech stocks are playing dice for the soul of the ASX Emerging Companies (XEC) index on Wednesday, as the small cap top...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX Small Cap index pops 1.4% rather nicely The top 200 ahead 1% AnteoTech and some clever diggers the big winners on Wednesday   The local small cap index is riding a mid-week mining boom with some standout individual performances from...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Genetic Technologies (GTG) inks a deal to buy UK-based DNA testing company AffinityDNA for £555,000 (A$985,000) GTG will pay 50 per cent of the cost paid upfront, with the remaining 50 per cent to be paid a year after subject to the financ...

Genetic Technologies buys out ecommerce company, AffinityDNA Regis Healthcare says it expects to be fully reimbursed by the government for its COVID-19 costs of $14m 4D Medical presents study data at renowned conference Genetic Tech buys...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The S&P/ASX 200 reclaimed more than 1% in Thursday trade after copping a straight hat-trick of losses. The major energy names and big Papa miners like Rio, Fortescue and BHP climbing strongly after falling even more strongly these last...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The ASX will head into the Anzac day long weekend on a slightly sour note following a Friday selloff. For the microcap Emerging Companies index, it was a ~1.5% fall on the day — but that didn’t stop another triple-digit percentage return, t...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Okay, who poked the S&P/ASX Emerging Companies index (XEC) this morning? Someone woke the sleeping Spinosaurus – the largest carnivorous dinosaur on this planet – that lies at the heart of our beloved small cap thermometer. It started r...

With Tuesday trade in the casket, the ASX Emerging Companies (XEC) index has closed about 1% lower, while the ASX 200 (XJO) benchmark index is down 0.5%, Everywhere markets fell, but for Paris, which has breathed a rich, garlic-scented merd...

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow...